-
2
-
-
4644245230
-
Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats
-
Fujisawa G, Okada K, Muto S, Fujita N, Itabashi N, Kusano E, Ishibashi S. Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats. Kidney Int 2004; 66:1493-1502.
-
(2004)
Kidney Int
, vol.66
, pp. 1493-1502
-
-
Fujisawa, G.1
Okada, K.2
Muto, S.3
Fujita, N.4
Itabashi, N.5
Kusano, E.6
Ishibashi, S.7
-
3
-
-
0034946204
-
Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats
-
Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol 2001; 133:687-694.
-
(2001)
Br J Pharmacol
, vol.133
, pp. 687-694
-
-
Miric, G.1
Dallemagne, C.2
Endre, Z.3
Margolin, S.4
Taylor, S.M.5
Brown, L.6
-
4
-
-
33751236177
-
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus
-
Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, et al. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology 2006; 147:5363-5373.
-
(2006)
Endocrinology
, vol.147
, pp. 5363-5373
-
-
Guo, C.1
Martinez-Vasquez, D.2
Mendez, G.P.3
Toniolo, M.F.4
Yao, T.M.5
Oestreicher, E.M.6
Kikuchi, T.7
-
5
-
-
33750331264
-
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes
-
Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, et al. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin J Am Soc Nephrol 2006; 1:940-951.
-
(2006)
Clin J Am Soc Nephrol
, vol.1
, pp. 940-951
-
-
Epstein, M.1
Williams, G.H.2
Weinberger, M.3
Lewin, A.4
Krause, S.5
Mukherjee, R.6
Patni, R.7
-
6
-
-
24144495285
-
Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: A randomized, double-masked, crossover study
-
Rossing K, Schjoedt KJ, Smidt UM, Boomsma F, Parving HH. Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, crossover study. Diabetes Care 2005; 28:2106-2112.
-
(2005)
Diabetes Care
, vol.28
, pp. 2106-2112
-
-
Rossing, K.1
Schjoedt, K.J.2
Smidt, U.M.3
Boomsma, F.4
Parving, H.H.5
-
7
-
-
0037222490
-
Effectiveness of aldosterone blockade in patients with diabetic nephropathy
-
Sato A, Hayashi K, Naruse M, Saruta T. Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 2003; 41:64-68.
-
(2003)
Hypertension
, vol.41
, pp. 64-68
-
-
Sato, A.1
Hayashi, K.2
Naruse, M.3
Saruta, T.4
-
8
-
-
58149125532
-
Effects of additive therapy with spironolactone on proteinuria in diabetic patients already on ACE inhibitor or ARB therapy: Results of a randomized, placebo-controlled, double-blind, crossover trial
-
Saklayen MG, Gyebi LK, Tasosa J, Yap J. Effects of additive therapy with spironolactone on proteinuria in diabetic patients already on ACE inhibitor or ARB therapy: results of a randomized, placebo-controlled, double-blind, crossover trial. J Invest Med 2008; 56:714-719.
-
(2008)
J Invest Med
, vol.56
, pp. 714-719
-
-
Saklayen, M.G.1
Gyebi, L.K.2
Tasosa, J.3
Yap, J.4
-
9
-
-
0033024642
-
Progression of diabetic nephropathy. Insights from cell culture studies and animal models
-
Phillips A, Janssen U, Floege J. Progression of diabetic nephropathy. Insights from cell culture studies and animal models. Kidney Blood Press Res 1999; 22:81-97.
-
(1999)
Kidney Blood Press Res
, vol.22
, pp. 81-97
-
-
Phillips, A.1
Janssen, U.2
Floege, J.3
-
10
-
-
0032728365
-
Mitogen-activated protein kinases as glucose transducers for diabetic complications
-
Tomlinson DR. Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 1999; 42:1271-1281.
-
(1999)
Diabetologia
, vol.42
, pp. 1271-1281
-
-
Tomlinson, D.R.1
-
11
-
-
2342522648
-
BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions
-
Suzaki Y, Yoshizumi M, KagamiS, Nishiyama A, Ozawa Y, Kyaw M, Izawa Y, et al. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kidney Int 2004; 65:1749-1760.
-
(2004)
Kidney Int
, vol.65
, pp. 1749-1760
-
-
Suzaki, Y.1
Yoshizumi, M.2
Kagamis Nishiyama, A.3
Ozawa, Y.4
Kyaw, M.5
Izawa, Y.6
-
12
-
-
12144286297
-
Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats
-
Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, et al. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 2004; 43:841-848.
-
(2004)
Hypertension
, vol.43
, pp. 841-848
-
-
Nishiyama, A.1
Yao, L.2
Nagai, Y.3
Miyata, K.4
Yoshizumi, M.5
Kagami, S.6
Kondo, S.7
-
13
-
-
20144365498
-
Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability
-
Nishiyama A, Yao L, Fan Y, Kyaw M, Kataoka N, Hashimoto K, Nagai Y, et al. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 2005; 45:710-716.
-
(2005)
Hypertension
, vol.45
, pp. 710-716
-
-
Nishiyama, A.1
Yao, L.2
Fan, Y.3
Kyaw, M.4
Kataoka, N.5
Hashimoto, K.6
Nagai, Y.7
-
14
-
-
31544473558
-
Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells
-
Miyata K, Rahman M, Shokoji T, Nagai Y, Zhang GX, Sun GP, Kimura S, et al. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J Am Soc Nephrol 2005; 16:2906-2912.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2906-2912
-
-
Miyata, K.1
Rahman, M.2
Shokoji, T.3
Nagai, Y.4
Zhang, G.X.5
Sun, G.P.6
Kimura, S.7
-
15
-
-
0034100147
-
Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
-
Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52:11-34.
-
(2000)
Pharmacol Rev
, vol.52
, pp. 11-34
-
-
Kim, S.1
Iwao, H.2
-
16
-
-
0033543549
-
Activation of the protein kinase ERK5/ BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus
-
Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/ BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 1999; 274:26563-26571.
-
(1999)
J Biol Chem
, vol.274
, pp. 26563-26571
-
-
Kamakura, S.1
Moriguchi, T.2
Nishida, E.3
-
17
-
-
31544473557
-
Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation
-
Ishizawa K, Izawa Y, Ito H, Miki C, Miyata K, Fujita Y, Kanematsu Y, et al. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation. Hypertension 2005; 46:1046-1052.
-
(2005)
Hypertension
, vol.46
, pp. 1046-1052
-
-
Ishizawa, K.1
Izawa, Y.2
Ito, H.3
Miki, C.4
Miyata, K.5
Fujita, Y.6
Kanematsu, Y.7
-
18
-
-
34548850880
-
Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells
-
Hitomi H, Kiyomoto H, Nishiyama A, Hara T, Moriwaki K, Kaifu K, Ihara G, et al. Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells. Hypertension 2007; 50:750-755.
-
(2007)
Hypertension
, vol.50
, pp. 750-755
-
-
Hitomi, H.1
Kiyomoto, H.2
Nishiyama, A.3
Hara, T.4
Moriwaki, K.5
Kaifu, K.6
Ihara, G.7
-
19
-
-
0032928614
-
Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
-
Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79:143-180.
-
(1999)
Physiol Rev
, vol.79
, pp. 143-180
-
-
Widmann, C.1
Gibson, S.2
Jarpe, M.B.3
Johnson, G.L.4
-
20
-
-
0029055761
-
Components of a new human protein kinase signal transduction pathway
-
Zhou G, Bao ZQ, Dixon JE. Components of a new human protein kinase signal transduction pathway. J Biol Chem 1995; 270:12665-12669.
-
(1995)
J Biol Chem
, vol.270
, pp. 12665-12669
-
-
Zhou, G.1
Bao, Z.Q.2
Dixon, J.E.3
-
21
-
-
0038025911
-
Stress and vascular responses: Atheroprotective effect of laminar fluid shear stress in endothelial cells: Possible role of mitogen-activated protein kinases
-
Yoshizumi M, Abe J, Tsuchiya K, Berk BC, Tamaki T. Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases. J Pharmacol Sci 2003; 91:172-176.
-
(2003)
J Pharmacol Sci
, vol.91
, pp. 172-176
-
-
Yoshizumi, M.1
Abe, J.2
Tsuchiya, K.3
Berk, B.C.4
Tamaki, T.5
-
22
-
-
31544477239
-
Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts
-
Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 2005; 46:1039-1045.
-
(2005)
Hypertension
, vol.46
, pp. 1039-1045
-
-
Nagai, Y.1
Miyata, K.2
Sun, G.P.3
Rahman, M.4
Kimura, S.5
Miyatake, A.6
Kiyomoto, H.7
-
23
-
-
0035538618
-
Mesangial cell dysfunction as a pathogenesis of diabetic nephropathy
-
Haneda M, Koya D, Kikkawa R. Mesangial cell dysfunction as a pathogenesis of diabetic nephropathy. Contrib Nephrol 2001; (134): 16-29.
-
(2001)
Contrib Nephrol
, Issue.134
, pp. 16-29
-
-
Haneda, M.1
Koya, D.2
Kikkawa, R.3
-
24
-
-
0034810884
-
Cellular mechanisms in the development and progression of diabetic nephropathy: Activation of the DAG-PKC-ERK pathway
-
Haneda M, Koya D, Kikkawa R. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis 2001; 38:S178-S181.
-
(2001)
Am J Kidney Dis
, vol.38
-
-
Haneda, M.1
Koya, D.2
Kikkawa, R.3
-
25
-
-
54149120307
-
The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation
-
Dorado F, Velasco S, Esparis-Ogando A, Pericacho M, Pandiella A, Silva J, Lopez-Novoa JM, et al. The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation. Nephrol Dial Transplant 2008; 23:3403-3411.
-
(2008)
Nephrol Dial Transplant
, vol.23
, pp. 3403-3411
-
-
Dorado, F.1
Velasco, S.2
Esparis-Ogando, A.3
Pericacho, M.4
Pandiella, A.5
Silva, J.6
Lopez-Novoa, J.M.7
-
26
-
-
25644434249
-
Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor
-
Xue C, Siragy HM. Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension 2005; 46:584-590.
-
(2005)
Hypertension
, vol.46
, pp. 584-590
-
-
Xue, C.1
Siragy, H.M.2
-
27
-
-
28444456990
-
Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A
-
Terada Y, Kobayashi T, Kuwana H, Tanaka H, Inoshita S, Kuwahara M, Sasaki S. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A. J Am Soc Nephrol 2005; 16:2296-2305.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2296-2305
-
-
Terada, Y.1
Kobayashi, T.2
Kuwana, H.3
Tanaka, H.4
Inoshita, S.5
Kuwahara, M.6
Sasaki, S.7
-
28
-
-
57349168398
-
Modification of mineralocorticoid receptor function by Rac1 GTPase: Implication in proteinuric kidney disease
-
Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14:1370-1376.
-
(2008)
Nat Med
, vol.14
, pp. 1370-1376
-
-
Shibata, S.1
Nagase, M.2
Yoshida, S.3
Kawarazaki, W.4
Kurihara, H.5
Tanaka, H.6
Miyoshi, J.7
-
30
-
-
54449090744
-
Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions
-
Wang H, Shimosawa T, Matsui H, Kaneko T, Ogura S, Uetake Y, Takenaka K, et al. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions. J Hypertens 2008; 26:1453-1462.
-
(2008)
J Hypertens
, vol.26
, pp. 1453-1462
-
-
Wang, H.1
Shimosawa, T.2
Matsui, H.3
Kaneko, T.4
Ogura, S.5
Uetake, Y.6
Takenaka, K.7
-
31
-
-
0036209325
-
Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells
-
Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 2002; 13:894-902.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 894-902
-
-
Ha, H.1
Yu, M.R.2
Choi, Y.J.3
Kitamura, M.4
Lee, H.B.5
-
32
-
-
21244485815
-
Mineralocorticoid receptors: Distribution and activation
-
Funder JW. Mineralocorticoid receptors: distribution and activation. Heart Fail Rev 2005; 10:15-22.
-
(2005)
Heart Fail Rev
, vol.10
, pp. 15-22
-
-
Funder, J.W.1
-
33
-
-
43449108835
-
Aldosterone in salt-sensitive hypertension and metabolic syndrome
-
Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med 2008; 86:729-734.
-
(2008)
J Mol Med
, vol.86
, pp. 729-734
-
-
Fujita, T.1
|